Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study tests whether a new medicine called TQH3906 can help control lupus, a chronic autoimmune disease. About 198 adults with lupus will receive either TQH3906 or a placebo. The main goal is to see if more people on the drug achieve a meaningful reduction in lupus activity b…

This study tests an experimental drug called TQ05105 in 51 people with intermediate or high-risk myelofibrosis, a rare bone marrow disorder. It is for patients whose disease has not responded to or has returned after standard JAK inhibitor therapy. The main goal is to see if the …

This study tests whether a combination of intravenous and inhaled polymyxin E2 can safely treat pneumonia caused by carbapenem-resistant bacteria in hospitalized or ventilated patients. About 48 adults will receive either the experimental treatment or a control. The goal is to se…

This early-stage study looks at how the drug anecatibin fumarate behaves in people with lung cancer who have different levels of liver function. Researchers will compare drug levels and safety in 24 adults with either impaired or normal liver function. The goal is to understand i…